杜氏肌肉发育不良症中的现实世界二胺酸摩尔福利诺寡合物治疗模式:基于索赔的分析
Shannon Grabich1, Brian Ung1, Aalok Nadkar1
1Sarepta Therapeutics, Inc, Cambridge, MA 02142 USA.
Journal of comparative effectiveness research
|July 18, 2025
概括
二胺酸形态寡合物 (PMOs) 在杜申肌肉发育不良 (DMD) 治疗中表现出很高的坚持性. 大多数在PMO治疗中出现差距的患者恢复治疗,这表明停止治疗的时间比之前报告的要小.
科学领域:
- 生物医学科学 生物医学科学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 杜氏肌肉发育不良 (DMD) 是一种渐进性的遗传性疾病.
- 二胺酸形态寡合物 (PMO) 是DMD的外跳转疗法.
- 了解治疗模式对于管理DMD至关重要.
研究的目的:
- 通过使用索赔数据,评估DMD患者PMO的治疗模式.
- 评估PMO治疗的坚持和重新启动率.
- 为了解决治疗评估的行政索赔数据的局限性.
主要方法:
- 分析2016年6月至2024年3月的行政索赔数据.
- 包括男性患者,要求获得美国批准的PMO治疗DMD.
- 评估持续的PMO索赔覆盖范围,缺口,重新启动和覆盖日数 (PDC) 的比例.
主要成果:
- 在397名患者中,47.9%和64.0%的患者分别经历了≥60和≥30天的间隔.
- 大多数患有缺口的患者重新开始PMO治疗 (57.9%和69.3%).
- 第一年的PDC中位数为78.8%;在门诊状态中,治疗模式类似.
结论:
- 根据索赔数据分析,对DMD的PMO治疗的坚持率很高.
- 缺口后的重新开始表明,停药率低于之前报告的.
- 索赔数据为DMD的现实世界PMO治疗模式提供了宝贵的见解.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
1.7K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
2.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
815
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
815


